Mustang Bio (MBIO) Cash from Operations (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Cash from Operations of 1008000.0 for Q1 2026, up 27.43% year-over-year from 791023.73 in Q1 2025, and up 41.33% quarter-over-quarter from 1718000.0 in Q4 2025.
Mustang Bio (MBIO) Cash from Operations (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Cash from Operations for 11 consecutive years, with 1008000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 27.43% year-over-year to 1008000.0; the TTM figure through Mar 2026 stood at 4883000.0 (up 34.7% YoY), while the FY2025 annual figure was 5264000.0, up 53.87% from the prior year.
- Cash from Operations advanced to 1008000.0 in Q1 2026 per MBIO's latest filing, from 1718000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 818000.0 in Q3 2025 and bottomed at 17808000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 7777941.18 across 5 years, with a median of 5321000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 45.31% — and 2024, when it soared 85.39%.
- Mustang Bio's Cash from Operations stood at 15289000.0 in 2022, then soared by 52.55% to 7254000.0 in 2023, then surged by 72.47% to 1997000.0 in 2024, then grew by 13.97% to 1718000.0 in 2025, then soared by 41.33% to 1008000.0 in 2026.
- Business Quant data shows MBIO's Cash from Operations at 1008000.0 in Q1 2026, 1718000.0 in Q4 2025, and 818000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | -967,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -967,000.00 |
| Jun 30, 2026 | -967,000.00 |
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Sep 30, 2025 | -818,000.00 |
| Sep 30, 2025 | -818,000.00 |
| Jun 30, 2025 | -1.34 Mn |
| Jun 30, 2025 | -1.34 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -2.34 Mn |
| Mar 31, 2024 | -5.32 Mn |
| Mar 31, 2024 | -5.32 Mn |